183 related articles for article (PubMed ID: 10452313)
1. Relative 99mTc-MAG3 renal uptake: reproducibility and accuracy.
Piepsz A; Tondeur M; Ham H
J Nucl Med; 1999 Jun; 40(6):972-6. PubMed ID: 10452313
[TBL] [Abstract][Full Text] [Related]
2. Study on 99mTc-MAG3 and 99mTc-DMSA renal accumulation using in vitro cellular model.
Nový Z; Mandíková J; Trejtnar F
Ceska Slov Farm; 2011 Feb; 60(1):7-10. PubMed ID: 21648170
[TBL] [Abstract][Full Text] [Related]
3. Comparison of differential renal function using technetium-99m mercaptoacetyltriglycine (MAG3) and technetium-99m dimercaptosuccinic acid (DMSA) renography in a paediatric population.
Ritchie G; Wilkinson AG; Prescott RJ
Pediatr Radiol; 2008 Aug; 38(8):857-62. PubMed ID: 18551288
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of renal function from 99mTc-MAG3 renography without blood sampling.
Inoue Y; Ohtake T; Yokoyama I; Yoshikawa K; Asai S; Ohtomo K
J Nucl Med; 1999 May; 40(5):793-8. PubMed ID: 10319752
[TBL] [Abstract][Full Text] [Related]
5. Diuretic MAG3 scintigraphy (F0) in acute pyelonephritis: regional parenchymal dysfunction and comparison with DMSA.
Sfakianakis GN; Cavagnaro F; Zilleruelo G; Abitbol C; Montane B; Georgiou M; Ezuddin S; Mallin W; Sfakianakis E; Strauss J
J Nucl Med; 2000 Dec; 41(12):1955-63. PubMed ID: 11138678
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of renal function with 99mTc-MAG3 using semiautomated regions of interest.
Inoue Y; Yoshikawa K; Yoshioka N; Watanabe T; Saegusa S; Kaneko Y; Yokoyama I; Ohtomo K
J Nucl Med; 2000 Dec; 41(12):1947-54. PubMed ID: 11138677
[TBL] [Abstract][Full Text] [Related]
7. Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy.
Melis M; de Swart J; de Visser M; Berndsen SC; Koelewijn S; Valkema R; Boerman OC; Krenning EP; de Jong M
J Nucl Med; 2010 Dec; 51(12):1962-8. PubMed ID: 21078795
[TBL] [Abstract][Full Text] [Related]
8. Differential renal function estimation by dynamic renal scintigraphy: influence of background definition and radiopharmaceutical.
Caglar M; Gedik GK; Karabulut E
Nucl Med Commun; 2008 Nov; 29(11):1002-5. PubMed ID: 18836380
[TBL] [Abstract][Full Text] [Related]
9. Background subtraction in technetium-99m-MAG3 renography.
Taylor A; Thakore K; Folks R; Halkar R; Manatunga A
J Nucl Med; 1997 Jan; 38(1):74-9. PubMed ID: 8998155
[TBL] [Abstract][Full Text] [Related]
10. The accuracy of quantitative parameters in (99m) Tc-MAG3 dynamic renography: a national audit based on virtual image data.
Brolin G; Edenbrandt L; Granerus G; Olsson A; Afzelius D; Gustafsson A; Jonsson C; Hagerman J; Johansson L; Riklund K; Ljungberg M
Clin Physiol Funct Imaging; 2016 Mar; 36(2):146-54. PubMed ID: 25348641
[TBL] [Abstract][Full Text] [Related]
11. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
Mustafa S; Elgazzar AH
J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
[TBL] [Abstract][Full Text] [Related]
12. Background correction in estimating initial renal uptake. Comparison between Tc-99m MAG3 and Tc-99m DTPA.
Inoue Y; Machida K; Honda N; Takahashi T; Mamiya T
Clin Nucl Med; 1994 Dec; 19(12):1049-54. PubMed ID: 7874800
[TBL] [Abstract][Full Text] [Related]
13. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA].
Lepej J; Marosová A; Kliment J; Buchanec J; Svitác J; Klisenbauer L
Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility and repeatability of differential renal function in 4-week-old piglets.
Dissing TH; Eskild-Jensen A; Pedersen M; Anderson PJ; Rittig N; Frøkiaer J; Gordon I
Nucl Med Commun; 2008 Jan; 29(1):76-82. PubMed ID: 18049100
[TBL] [Abstract][Full Text] [Related]
15. Estimation of differential renal function by means of 99mTc-MAG3: integral method or Rutland-Patlak plot?
Piepsz A; Ham H
Eur J Nucl Med; 1999 Dec; 26(12):1627-8. PubMed ID: 10638417
[No Abstract] [Full Text] [Related]
16. A simple method for determining split renal function from dynamic (99m)Tc-MAG3 scintigraphic data.
Wesolowski MJ; Conrad GR; Šámal M; Watson G; Wanasundara SN; Babyn P; Wesolowski CA
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):550-8. PubMed ID: 26537286
[TBL] [Abstract][Full Text] [Related]
17. Measurement of renal function by calculation of fractional uptake of technetium-99m dimercaptosuccinic acid.
Beatović SLj; Jaksić ED; Han RS
Nucl Med Rev Cent East Eur; 2004; 7(1):49-52. PubMed ID: 15318311
[TBL] [Abstract][Full Text] [Related]
18. The renal parenchyma evaluation: MAG3 vs. DMSA.
Smokvina A; Grbac-Ivanković S; Girotto N; Dezulović MS; Saina G; Barković MM
Coll Antropol; 2005 Dec; 29(2):649-54. PubMed ID: 16417177
[TBL] [Abstract][Full Text] [Related]
19. Assessment of renal function in mice with unilateral ureteral obstruction using 99mTc-MAG3 dynamic scintigraphy.
Tantawy MN; Jiang R; Wang F; Takahashi K; Peterson TE; Zemel D; Hao CM; Fujita H; Harris RC; Quarles CC; Takahashi T
BMC Nephrol; 2012 Dec; 13():168. PubMed ID: 23228112
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume.
Esteves FP; Taylor A; Manatunga A; Folks RD; Krishnan M; Garcia EV
AJR Am J Roentgenol; 2006 Dec; 187(6):W610-7. PubMed ID: 17114514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
